Table 2 Pretreatment characteristics, (n=2610)
From: Early toxicity predicts long-term survival in high-grade glioma
N | % | |
|---|---|---|
Age | ||
<50 | 907 | 34 |
⩽50 | 1691 | 65 |
Unknown/missing | 12 | <1 |
Zubrod | ||
0 | 1294 | 50 |
1, 2, 3 | 1304 | 50 |
Unknown/missing | 12 | <1 |
Surgery | ||
Biopsy | 650 | 25 |
Partial/total resection | 1900 | 73 |
Other/unknown/missing | 70 | 2 |
Neurological dysfunction | ||
None/minor | 1631 | 62 |
Moderate/severe | 961 | 36 |
Unknown/missing | 18 | 1 |
Mental status | ||
Normal function | 1725 | 66 |
Minor, gross confusion | 706 | 27 |
Unknown/missing | 179 | 7 |
RPA class | ||
I, II | 183 | 7 |
III | 410 | 16 |
IV | 1043 | 40 |
V, VI | 844 | 33 |
Unknown | 130 | 5 |
Histology | ||
GBM | 2233 | 86 |
AA | 250 | 10 |
Other | 127 | 5 |
Twice-daily RT | ||
No | 1397 | 54 |
Yes | 1213 | 46 |
Chemotherapy | ||
No | 431 | 17 |
Yes | 2179 | 83 |
Biological drug | ||
No | 2179 | 83 |
Yes | 431 | 17 |
Biological-equivalent dose | ||
⩽120 | 2344 | 90 |
>120 | 266 | 10 |
